Ferroptosis, a novel form of programmed cell death, is characterized by iron-dependent lipid peroxidation and has been shown to be involved in multiple diseases, including cancer. Stimulating ferroptosis in cancer cells may be a potential strategy for cancer therapy. Therefore, ferroptosis-inducing drugs are attracting more attention for cancer treatment. Here, we showed that erianin, a natural product isolated from Dendrobium chrysotoxum Lindl, exerted its anticancer activity by inducing cell death and inhibiting cell migration in lung cancer cells. Subsequently, we demonstrated for the first time that erianin induced ferroptotic cell death in lung cancer cells, which was accompanied by ROS accumulation, lipid peroxidation, and GSH depletion. The ferroptosis inhibitors Fer-1 and Lip-1 but not Z-VAD-FMK, CQ, or necrostatin-1 rescued erianin-induced cell death, indicating that ferroptosis contributed to erianin-induced cell death. Furthermore, we demonstrated that Ca2+/CaM signaling was a critical mediator of erianin-induced ferroptosis and that blockade of this signaling significantly rescued cell death induced by erianin treatment by suppressing ferroptosis. Taken together, our data suggest that the natural product erianin exerts its anticancer effects by inducing Ca2+/CaM-dependent ferroptosis and inhibiting cell migration, and erianin will hopefully serve as a prospective compound for lung cancer treatment.

Iron, nitrogen‐codoped carbon (Fe−N−C) nanocomposites have emerged as viable electrocatalysts for the oxygen reduction reaction (ORR) due to the formation of FeNxCy coordination moieties. In this study, results from first‐principles calculations show a nearly linear correlation of the energy barriers of key reaction steps with the Fe magnetic moment. Experimentally, when single Cu sites are incorporated into Fe−N−C aerogels (denoted as NCAG/Fe−Cu), the Fe centers exhibit a reduced magnetic moment and markedly enhanced ORR activity within a wide pH range of 0–14. With the NCAG/Fe−Cu nanocomposites used as the cathode catalyst in a neutral/quasi‐solid aluminum–air and alkaline/quasi‐solid zinc–air battery, both achieve a remarkable performance with an ultrahigh open‐circuit voltage of 2.00 and 1.51 V, large power density of 130 and 186 mW cm−2, and good mechanical flexibility, all markedly better than those with commercial Pt/C or Pt/C‐RuO2 catalysts at the cathode.

No abstract

Gases generated from lithium batteries are detrimental to their electrochemical performances, especially under the unguarded runaway conditions, which tend to contribute the sudden gases accumulation (including flammable gases), resulting in safety issues such as explosion and combustion. The comprehensive understanding of battery gas evolution mechanism under different conditions is extremely important, which is conducive to realizing a visual cognition about the complex reaction processes between electrodes and electrolytes, and providing effective strategies to optimize battery performances. This review aims to summarize the recent progress about battery gas evolution mechanism and highlight the gas suppression strategies to improve battery safety. New approaches toward future gas evolution analysis and suppression are also proposed. It is anticipated that this review will inspire further developments of lithium batteries on performance, gas suppression, and safety, especially in high energy density systems.

BackgroundOsteopontin (OPN), a member of the small integrin binding ligand N-linked glycoprotein family, has been analyzed in numerous types of human malignancy.PurposeThe present study detected the expression levels of OPN and evaluated its role in tumor progression in patients with non-small cell lung cancer (NSCLC).Patients and methodsOPN expression levels were detected using immunohistochemistry in 101 NSCLC tumors. The mRNA and protein levels have significant difference between advanced NSCLC and stage I/II NSCLC. The drug resistance, invasive ability and lactate production of NSCLC cancer cell lines (A549 and SK-MES-1) were detected in cancer cells with the disturbance of OPN.ResultsImmunostaining indicated that OPN was primarily expressed in the cytoplasm of NSCLC cells. Moreover, OPN correlates with NSCLC clinical traits. The results demonstrated that OPN expression levels significantly correlated with cancer differentiation, distant metastasis and the efficacy of platinum-based treatment. Notably, the results identified OPN expression levels as a potential factor for predicting the response of cells to first-line platinum-based chemotherapy using multivariate analysis, as well as predicting cancer differentiation and distant metastasis. Additionally, the abrogation of OPN levels reduced lactate production in NSCLC cells and occurred along side with the downregulation of lactate dehydrogenase A (LDHA).ConclusionThe results of the current study suggest that OPN may be able to predict poor prognosis and cisplatin resistance in patients.